Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors [Pharmacology]

Many ion channels, including Nav1.7, Cav1.3, and Kv1.3, are linked to human pathologies and are important therapeutic targets. To develop efficacious and safe drugs, subtype-selective modulation is essential, but has been extremely difficult to achieve. We postulate that this challenge is caused by the poor assay design, and investigate the...

http://ift.tt/2n6xDCE